Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?
- 27 January 2010
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 41 (2-3) , 87-96
- https://doi.org/10.1007/s12035-009-8095-7
Abstract
Mitochondria are dynamic organelles that undergo continuous fission and fusion, which could affect all aspects of mitochondrial function. Mitochondrial dysfunction has been well documented in Alzheimer’s disease (AD). In the past few years, emerging evidence indicates that an imbalance of mitochondrial dynamics is involved in the pathogenesis of AD. In this review, we discuss in detail the abnormal mitochondrial dynamics in AD and how such abnormal dynamics may impact mitochondrial and neuronal function and contribute to the course of disease. Based on this discussion, we propose that mitochondrial dynamics could be a potential therapeutic target for AD.Keywords
This publication has 149 references indexed in Scilit:
- Abnormal mitochondrial dynamics and neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's diseaseExperimental Neurology, 2009
- The effect of acetyl-L-carnitine and R-α-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's diseaseJournal of the Neurological Sciences, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's diseaseDNA Repair, 2008
- Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell deathBrain Research, 2008
- Chemical Inhibition of the Mitochondrial Division Dynamin Reveals Its Role in Bax/Bak-Dependent Mitochondrial Outer Membrane PermeabilizationPublished by Elsevier ,2008
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008
- Developing pharmacological therapies for Alzheimer diseaseCellular and Molecular Life Sciences, 2007
- OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28Nature Genetics, 2000